INFLUVAC TETRA, SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 ML

INJECTION, SUSPENSION

**4.2. Posology and method of administration** Posology Adults: 0.5 ml. _Pediatric patients_ Children from 6 months to 17 years of age: 0.5 ml. Children less than 9 years of age, who have not previously been vaccinated with a seasonal influenza vaccine: a second dose of 0.5 ml should be given after an interval of at least 4 weeks. Infants less than 6 months of age: the safety and efficacy of Influvac® Tetra in infants have not been established. Method of Administration Immunization should be carried out by intramuscular or deep subcutaneous injection. The preferred sites for intramuscular injection are the anterolateral aspect of the thigh (or the deltoid muscle if muscle mass is adequate) in children 6 months through 35 months of age, or the deltoid muscle in children from 36 months of age and adults. Precautions to be taken before handling or administrating the medicinal product: For instructions for preparation of the medicinal product before administration, see section 6.6 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.